Hohl Benjamin

Enliven Therapeutics, Inc. · CHIEF FINANCIAL OFFICER

Hohl Benjamin is listed in filings as CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 10, 2026, including sale activity. Recent filings connect the profile to Enliven Therapeutics, Inc. (ELVN). The current snapshot covers public activity from Jul 1, 2024 to Mar 10, 2026. Reported amounts are shown as $295.8K to $32.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

Company	Value	Action	Price	Last Price
Enliven Therapeutics, Inc.ELVN	$66k3.3k shares	SellSep 29, 2025	$20.40	$53.20
Enliven Therapeutics, Inc.ELVN	$67k3.3k shares	SellAug 27, 2025	$20.63	$53.20
Enliven Therapeutics, Inc.ELVN	$1.4k65 shares	SellJul 28, 2025	$21.30	$53.20
Enliven Therapeutics, Inc.ELVN	$65k3.2k shares	SellJul 28, 2025	$20.45	$53.20
Enliven Therapeutics, Inc.ELVN	$23k1k shares	SellJul 10, 2025	$22.66	$53.20
Enliven Therapeutics, Inc.ELVN	$4.3k198 shares	SellJun 27, 2025	$21.66	$53.20
Enliven Therapeutics, Inc.ELVN	$64k3.1k shares	SellJun 27, 2025	$20.86	$53.20
Enliven Therapeutics, Inc.ELVN	$68k3k shares	SellJun 13, 2025	$22.55	$53.20
Enliven Therapeutics, Inc.ELVN	$53k3.3k shares	SellMay 27, 2025	$16.18	$53.20
Enliven Therapeutics, Inc.ELVN	$1.3k69 shares	SellApr 28, 2025	$19.12	$53.20
Enliven Therapeutics, Inc.ELVN	$59k3.2k shares	SellApr 28, 2025	$18.68	$53.20
Enliven Therapeutics, Inc.ELVN	$69k3.3k shares	SellMar 27, 2025	$21.33	$53.20
Enliven Therapeutics, Inc.ELVN	$23k1k shares	SellMar 24, 2025	$22.50	$53.20
Enliven Therapeutics, Inc.ELVN	$66k3.3k shares	SellFeb 27, 2025	$20.41	$53.20
Enliven Therapeutics, Inc.ELVN	$23k1k shares	SellFeb 5, 2025	$22.52	$53.20
Enliven Therapeutics, Inc.ELVN	$70k3.3k shares	SellJan 27, 2025	$21.59	$53.20
Enliven Therapeutics, Inc.ELVN	$25k1k shares	SellJan 3, 2025	$25.04	$53.20
Enliven Therapeutics, Inc.ELVN	$20k900 shares	SellDec 30, 2024	$22.51	$53.20
Enliven Therapeutics, Inc.ELVN	$74k3.4k shares	SellDec 27, 2024	$22.15	$53.20
Enliven Therapeutics, Inc.ELVN	$105k4.3k shares	SellNov 27, 2024	$24.78	$53.20
Enliven Therapeutics, Inc.ELVN	$25k1k shares	SellNov 27, 2024	$25.38	$53.20
Enliven Therapeutics, Inc.ELVN	$160k5.6k shares	SellOct 28, 2024	$28.49	$53.20
Enliven Therapeutics, Inc.ELVN	$19k650 shares	SellOct 28, 2024	$29.11	$53.20
Enliven Therapeutics, Inc.ELVN	$24k814 shares	SellOct 18, 2024	$30.00	$53.20
Enliven Therapeutics, Inc.ELVN	$35k1.3k shares	SellOct 7, 2024	$27.51	$53.20
Enliven Therapeutics, Inc.ELVN	$281k10.2k shares	SellOct 4, 2024	$27.51	$53.20
Enliven Therapeutics, Inc.ELVN	$14k521 shares	SellOct 1, 2024	$27.54	$53.20
Enliven Therapeutics, Inc.ELVN	$51k2k shares	SellSep 30, 2024	$25.33	$53.20
Enliven Therapeutics, Inc.ELVN	$103k4.3k shares	SellSep 27, 2024	$24.27	$53.20
Enliven Therapeutics, Inc.ELVN	$96k4.3k shares	SellAug 27, 2024	$22.54	$53.20
Enliven Therapeutics, Inc.ELVN	$27k991 shares	SellJul 31, 2024	$27.53	$53.20
Enliven Therapeutics, Inc.ELVN	$1.7k61 shares	SellJul 29, 2024	$27.44	$53.20
Enliven Therapeutics, Inc.ELVN	$138k5.2k shares	SellJul 29, 2024	$26.67	$53.20
Enliven Therapeutics, Inc.ELVN	$75k3k shares	SellJul 12, 2024	$25.07	$53.20
Enliven Therapeutics, Inc.ELVN	$41k1.8k shares	SellJun 27, 2024	$22.58	$53.20
Enliven Therapeutics, Inc.ELVN	$28k1.3k shares	SellJun 27, 2024	$21.79	$53.20
Enliven Therapeutics, Inc.ELVN	$27k1.1k shares	SellJun 27, 2024	$23.43	$53.20